Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events

PURPOSE: To capture UK societal health utility values for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and the disutility associated with treatment-related adverse events (AEs) to inform future cost–utility analyses. METHODS: A literature review, and patient and clinical expert int...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Qual Life Res
Main Authors: Hall, F., de Freitas, H. M., Kerr, C., Ito, T., Nafees, B., Lloyd, A. J., Penton, J., Hadi, M., Lanar, S., Pham, T. P.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6470112/
https://ncbi.nlm.nih.gov/pubmed/30767088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11136-019-02117-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados